About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

1 1 (February 7, 2020)

handle is hein.crs/govcagw0001 and id is 1 raw text is: 















Scheduling of Fentanyl Analogues: The New

Legal Landscape



February 7, 2020

In the most recent change to federal law in response to the opioid crisis, on February 6, 2020, the
President signed the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl
Analogues Act (the Act). The Act temporarily extended a Drug Enforcement Administration (DEA)
administrative order that placed certainfentanyl analogues-i.e., compounds related to the powerful
synthetic opioid fentanyl-under control pursuant to the Controlled Substances Act (CSA). This Sidebar
provides an overview of key legal issues related to the scheduling of fentanyl analogues and recent
changes to the law.

The CSA and Controlled Substance Scheduling
The CSA regulates drugs and other substances-whether medical or recreational, legally or illicitly
distributed-that pose a risk of abuse and dependence. Substances become subject to the CSA through
placement in one of five lists, known as Schedules I through V A lower schedule number carries greater
restrictions, so controlled substances in Schedule I are subject to the most stringent controls. Placement in
Schedule I reflects a finding that a substance has a high potential for abuse and no currently accepted
medical use. Substances in Schedules II through V have accepted medical uses and pose progressively
lower risks of abuse and dependence. Fentanyl itself is in Schedule II, as it has recognized medical uses
such as pain management for cancer patients. Multiple nonpharmaceutical substances related to fentanyl
are controlled in Schedule I. Cough medicines containing limited amounts of the opiate codeine are in
Schedule V. (Many other prescription drugs are not controlled substances subject to the CSA.)
A substance not specifically designated for control in Schedules I through V may still be subject to the
CSA as a controlled substance analogue. A controlled substance analogue is a substance not otherwise
approved by the Food and Drug Administration (FDA) or scheduled under the CSA that has (1) a
chemical structure substantially similar to that of a controlled substance in Schedule I or II, or (2) an
actual or intended effect that is substantially similar to or greater than the stimulant, depressant, or
hallucinogenic effect ... of a controlled substance in schedule I or II. A substance that meets those
criteria and is intended for human consumption is treated as a controlled substance in Schedule i.
Synthetic opioids related to fentanyl may qualify as controlled substance analogues. However, as a
practical matter, treatment as controlled substance analogues may allow for less effective control than if

                                                                  Congressional Research Service
                                                                    https://crsreports.congress.gov
                                                                                       LSB10404

CRS Lega Sidebar
Prepaed for Membeivs and
Cornm ittees  o4 Cor~qress  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Already a HeinOnline Subscriber?

profiles profiles most